Samlyn Capital’s Climb Bio, Inc. Common Stock CLYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,130,237
Closed -$17.9M 122
2022
Q1
$17.9M Buy
2,130,237
+426,691
+25% +$3.58M 0.26% 74
2021
Q4
$17.8M Buy
1,703,546
+22,521
+1% +$236K 0.25% 69
2021
Q3
$30.2M Buy
+1,681,025
New +$30.2M 0.4% 57